Hashimoto's and pregnancy is absolutely manageable — but it requires proactive monitoring that goes beyond routine prenatal care. The fetus depends entirely on maternal thyroid hormones for brain development during the first trimester, TSH targets are trimester-specific and lower than non-pregnant ranges, and your levothyroxine dose will almost certainly need to increase.
This guide covers what the research says about fertility, trimester-specific management, safe and unsafe supplements, and the postpartum period — the phase most women are underprepared for.
Medical disclaimer: This article is educational only. Pregnancy with Hashimoto's requires close collaboration between your endocrinologist and obstetrician. Do not adjust medications without medical guidance. Every pregnancy is different.
How Pregnancy Changes Your Thyroid

Pregnancy transforms thyroid physiology in four ways that every Hashimoto's patient needs to understand:
1. hCG Stimulates the Thyroid
Human chorionic gonadotropin (hCG), the pregnancy hormone, structurally resembles TSH and directly stimulates the thyroid. In the first trimester, rising hCG can transiently suppress TSH — this is normal, not hyperthyroidism. In Hashimoto's patients with limited thyroid reserve, this hCG boost may be the only thing maintaining adequate hormone levels early on.
2. Immune Suppression — You May Feel Better
Pregnancy induces a natural shift toward regulatory T cell (Treg) dominance to prevent immune rejection of the fetus. For Hashimoto's patients, this often means reduced autoimmune attack on the thyroid. Many women report feeling their best during pregnancy — less fatigue, better mood, fewer flares.
The problem comes after delivery (see postpartum section below).
3. Iodine Requirements Increase 50%
The recommended iodine intake rises from 150 mcg to 220–250 mcg during pregnancy. The fetus requires iodine for its own thyroid hormone production starting around week 12. However, in Hashimoto's patients, excess iodine can worsen autoimmunity — a delicate balance. Most prenatal vitamins contain 150 mcg of iodine, which combined with dietary intake is usually sufficient. Do not add supplemental iodine beyond your prenatal without testing.
4. Thyroxine-Binding Globulin Rises
Estrogen increases TBG (thyroxine-binding globulin) levels 2–3 fold during pregnancy. TBG binds circulating T4, reducing the free fraction. This is the primary reason levothyroxine requirements increase — more binding protein means you need more total hormone to maintain the same free hormone levels.
Trimester-Specific TSH Targets
Pregnancy TSH Targets — ATA 2017 Guidelines
Trimester-specific targets for Hashimoto's patients
First Trimester
Weeks 1–12
Optimal
0.1–2.5 mIU/L
Borderline
2.5–4.0 mIU/L
Action Needed
>4.0 mIU/L
Monitoring
Every 4 weeks
Second Trimester
Weeks 13–26
Optimal
0.2–3.0 mIU/L
Borderline
3.0–4.0 mIU/L
Action Needed
>4.0 mIU/L
Monitoring
Every 4–6 weeks
Third Trimester
Weeks 27–40
Optimal
0.3–3.5 mIU/L
Borderline
3.5–4.5 mIU/L
Action Needed
>4.5 mIU/L
Monitoring
Every 6–8 weeks
First Trimester (Weeks 1–12)
Second Trimester (Weeks 13–26)
Third Trimester (Weeks 27–40)
Source: American Thyroid Association (ATA) 2017 Guidelines for Diagnosis and Management of Thyroid Disease During Pregnancy (Alexander et al. 2017). Borderline ranges reflect population-specific reference adjustments now recommended by ATA.
The 2017 American Thyroid Association (ATA) guidelines (Alexander et al.) establish trimester-specific TSH reference ranges:
| Trimester | TSH Target | Why |
|---|---|---|
| First (weeks 1–12) | < 2.5 mIU/L | Fetus entirely dependent on maternal T4 for brain development |
| Second (weeks 13–27) | < 3.0 mIU/L | Fetal thyroid begins producing hormones but still needs maternal supply |
| Third (weeks 28–40) | < 3.5 mIU/L | Fetal thyroid increasingly independent but maternal support continues |
Why the first trimester matters most: The fetal thyroid does not begin functioning until approximately week 12–14. Before that, every molecule of thyroid hormone the developing brain receives comes from the mother. Maternal hypothyroidism during this window is associated with impaired neurodevelopment (Haddow et al. 1999, Lazarus et al. 2012 CATS trial).
Monitoring Schedule
- Pre-conception to week 20: TSH every 4 weeks
- Weeks 20–36: TSH every 6–8 weeks (if stable)
- Include FT4 at each check — TSH alone can be misleading during pregnancy due to hCG effects
- Antibody check once per trimester if not previously confirmed
Hashimoto's and Fertility
Hashimoto's affects fertility through multiple mechanisms, and it is underdiagnosed in the fertility setting.
Subclinical Hypothyroidism Reduces Fertility
Maraka et al. (2017) meta-analysis demonstrated that subclinical hypothyroidism (TSH 4.5–10 with normal FT4) is associated with:
- Impaired ovulation and luteal phase defects
- Reduced implantation rates
- Higher miscarriage risk (relative risk ~1.8)
TPO Antibodies Alone Increase Miscarriage Risk
This is the finding most often missed: Negro et al. 2006 showed that women with TPO antibodies — even with completely normal TSH — have a 2–3x higher miscarriage rate than antibody-negative women. The mechanism likely involves direct immune effects on the endometrium and placenta, independent of thyroid hormone levels.
Clinical implication: If you are TPO-positive and trying to conceive, most reproductive endocrinologists recommend levothyroxine to keep TSH below 2.5, regardless of whether TSH is technically "normal."
What to Do Before Conception
- Full thyroid panel: TSH, FT4, FT3, TPOAb, TgAb
- Target TSH < 2.5 — start or adjust levothyroxine if above
- Optimize vitamin D to 60–80 ng/mL
- Replete iron — ferritin target > 70 ng/mL
- Start prenatal with methylfolate (not folic acid) at least 3 months before
- Consider selenium 200 mcg/day (Negro 2007 — reduces postpartum thyroiditis risk)
- Discontinue LDN, ashwagandha, berberine, and all peptides
Medication Management During Pregnancy
The "Two Extra Pills" Rule
The standard recommendation from the ATA: as soon as you get a positive pregnancy test, add two extra levothyroxine doses per week (approximately 30% increase). Then titrate based on labs at your first OB visit (ideally within 1–2 weeks).
Do not wait for symptoms. Do not wait for lab results. The dose increase should happen immediately — the first trimester is the highest-risk window.
Levothyroxine Dose Trajectory
Most women need a 30–50% dose increase by mid-pregnancy. The increase happens gradually:
- Weeks 4–8: 30% increase (the two-extra-pill adjustment)
- Weeks 8–20: Further titration as needed based on 4-week labs
- Weeks 20–40: Usually stable, minor adjustments only
- Postpartum: Return to pre-pregnancy dose immediately after delivery
NDT (Desiccated Thyroid) in Pregnancy
Natural desiccated thyroid (Armour, NP Thyroid) contains both T4 and T3. It is less studied in pregnancy than levothyroxine. Some endocrinologists switch patients to levothyroxine during pregnancy for more predictable dosing. Discuss with your provider — this is a physician-level decision, not a DIY choice.
Absorption Matters More Than Ever
Morning sickness, prenatal vitamins (contain iron and calcium), and dietary changes all affect levothyroxine absorption. Maintain the 30–60 minute fasting window between levothyroxine and food/supplements. If morning sickness makes morning dosing impossible, evening dosing (3+ hours after dinner) is an acceptable alternative.
Safe Supplements During Pregnancy
Evidence Grade Key: Grade A = multiple RCTs or meta-analyses. Grade B = single RCT, strong clinical evidence. Grade C = preliminary or mechanistic evidence only.
Safe and Recommended
| Supplement | Grade | Dose | Evidence |
|---|---|---|---|
| Prenatal with methylfolate | A | Per label | Neural tube defect prevention; methylfolate preferred over folic acid for MTHFR variants |
| Omega-3 DHA | A | 200–600 mg DHA | Fetal brain development + anti-inflammatory (Middleton 2018 Cochrane review) |
| Vitamin D3 | B | 4,000 IU/day | Immune modulation + fetal development; safe dose confirmed by Hollis 2011 RCT |
| Selenium | B | 200 mcg selenomethionine | Negro 2007 RCT: reduced postpartum thyroiditis from 48.6% to 28.6% |
| Iron (if deficient) | A | 25–50 mg bisglycinate | Per ferritin levels; separate from levothyroxine by 4+ hours |
| Probiotics | B | 10–50B CFU multi-strain | Immune modulation; Lactobacillus and Bifidobacterium strains well-studied in pregnancy |
| Magnesium | B | 200–400 mg glycinate | Sleep, muscle cramps, cofactor for vitamin D metabolism |
AVOID During Pregnancy
| Supplement | Reason |
|---|---|
| Ashwagandha | Insufficient pregnancy safety data; potential uterotonic effects; nightshade family |
| Berberine | May cause uterine contractions; contraindicated in pregnancy |
| LDN | Insufficient pregnancy data — discontinue before conception attempts |
| BPC-157, TB-500, KPV | No human pregnancy studies for any peptides |
| High-dose iodine (>250 mcg) | Can worsen Hashimoto's antibodies; excess crosses placenta |
| Excess vitamin A (>10,000 IU retinol) | Teratogenic risk; beta-carotene form is safe |
| Guggul / Forskolin | Uterine stimulant effects reported |
For full supplement deep-dives: Supplements for Hashimoto's →
Postpartum Thyroiditis: The Phase Most Women Miss
Postpartum thyroiditis is the most underprepared-for complication of Hashimoto's and pregnancy. It affects 33–50% of TPO-positive women within 12 months of delivery.
The Biphasic Pattern
Phase 1 — Hyperthyroid (months 1–4 postpartum): The immune rebound after delivery attacks the thyroid aggressively. Stored thyroid hormones leak from damaged follicles into the bloodstream. Symptoms: anxiety, heart palpitations, tremor, weight loss, insomnia. This is often mistaken for postpartum anxiety or "just being a new mom."
Phase 2 — Hypothyroid (months 4–8 postpartum): After the stored hormones are depleted, the damaged thyroid cannot produce enough. Symptoms: crushing fatigue, depression, brain fog, weight gain, hair loss. This is commonly misdiagnosed as postpartum depression.
Recovery and Permanent Hypothyroidism
- 70–80% recover within 12 months (thyroid function normalizes)
- 20–30% progress to permanent hypothyroidism requiring lifelong medication
- Women who develop postpartum thyroiditis have a 70% chance of recurrence in subsequent pregnancies
Selenium for Prevention
The Negro 2007 RCT is the landmark study: 200 mcg selenium supplementation during pregnancy and postpartum reduced postpartum thyroiditis incidence from 48.6% to 28.6% in TPO-positive women. This is one of the strongest arguments for routine selenium supplementation in Hashimoto's patients planning pregnancy.
Deep dive: Selenium for Hashimoto's →
Postpartum Monitoring Protocol
- TSH + FT4 at 6 weeks, 3 months, 6 months, and 12 months postpartum
- If symptoms arise between scheduled tests, check labs immediately
- Do not assume fatigue or mood changes are "just normal new mom stuff" — test first
Breastfeeding Considerations
Levothyroxine is safe during breastfeeding. It is excreted in breast milk in negligible amounts and does not affect infant thyroid function.
Other considerations:
- Continue selenium 200 mcg — safe during breastfeeding
- Continue vitamin D, omega-3, and iron as needed
- Ashwagandha, berberine, and peptides remain avoided during breastfeeding (insufficient safety data)
- If postpartum hypothyroid phase requires starting/increasing levothyroxine, do not delay treatment for breastfeeding — it is safe
Planning Your Next Pregnancy
If you have had one pregnancy with Hashimoto's, preparation for the next one starts months before conception:
- Retest full thyroid panel — confirm current antibody levels and thyroid function
- Target TSH < 2.5 before attempting conception
- Replete nutrient stores — ferritin > 70, vitamin D 60–80, adequate B12
- Start selenium 200 mcg at least 3 months before conception
- Address any postpartum thyroiditis from the previous pregnancy — is thyroid function fully stable?
- Discuss medication plan with your endocrinologist before conception, not after the positive test
Take the Quiz
Managing Hashimoto's during pregnancy is just one piece of the puzzle. Take our free 3-minute quiz → to get a personalized protocol based on your condition, symptoms, and current health status.
Frequently Asked Questions
Q: Can you have a healthy pregnancy with Hashimoto's? Yes. With proper monitoring and medication management, pregnancy outcomes are excellent. The key is maintaining trimester-specific TSH targets and proactive dose adjustment.
Q: Does Hashimoto's affect fertility? Yes — both subclinical hypothyroidism and TPO antibodies alone are associated with reduced fertility and higher miscarriage risk. Target TSH < 2.5 before conception.
Q: Should I take selenium during pregnancy? Negro 2007 showed selenium 200 mcg reduced postpartum thyroiditis from 48.6% to 28.6%. It is generally considered safe at this dose. Confirm with your obstetrician.
Q: What supplements should I avoid during pregnancy? Ashwagandha, berberine, LDN, all peptides (BPC-157, TB-500, KPV), high-dose iodine (>250 mcg), and excess vitamin A.
Q: Can Hashimoto's flare after pregnancy? Yes — the immune rebound postpartum is the mechanism behind postpartum thyroiditis, affecting 33–50% of TPO-positive women. Close monitoring in the first 12 months postpartum is essential.
References
- Alexander EK et al. (2017). "2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum." Thyroid 27(3): 315–389.
- Negro R et al. (2006). "Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetric complications." Journal of Clinical Endocrinology & Metabolism 91(7): 2587–2591.
- Negro R et al. (2007). "The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies." Journal of Clinical Endocrinology & Metabolism 92(4): 1263–1268.
- Maraka S et al. (2017). "Subclinical hypothyroidism in pregnancy: a systematic review and meta-analysis." Thyroid 27(8): 999–1007.
- Lazarus JH et al. (2012). "Antenatal thyroid screening and childhood cognitive function." New England Journal of Medicine 366(6): 493–501.
- Korevaar TIM et al. (2017). "Thyroid disease in pregnancy: new insights in diagnosis and clinical management." Nature Reviews Endocrinology 13(10): 610–622.
- Hollis BW et al. (2011). "Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness." Journal of Bone and Mineral Research 26(10): 2341–2357.
This article is for educational purposes only and does not constitute medical advice. Pregnancy with Hashimoto's requires ongoing medical supervision. Always work with your endocrinologist and obstetrician for medication and supplement decisions during pregnancy.